What Is Cancer? - NCI
Oct 11, 2021 · Explanations about what cancer is, how cancer cells differ from normal cells, and genetic changes that cause cancer to grow and spread.
Overall Cancer Statistics - Annual Report to the Nation
The Annual Report to the Nation on the Status of Cancer has statistics on cancer deaths and new cases (incidence).
A to Z List of Cancer Types - NCI
Common Cancer Types Bladder Cancer Breast Cancer Colorectal Cancer Kidney (Renal Cell) Cancer Lung Cancer Lymphoma Pancreatic Cancer Prostate Cancer Skin Cancer Uterine …
Surveillance, Epidemiology, and End Results Program
Jan 6, 2026 · An authoritative source for cancer statistics in the US. We collect incidence, prevalence and survival data and publish reports on these and cancer mortality. For those …
Study Pinpoints Potential Ovarian Cancer Driver - NCI
Apr 24, 2025 · Only about one-third of women with advanced high-grade serous ovarian cancer live for 5 years or more after diagnosis. These statistics have spurred researchers to try to find …
Red Meat and Processed Meat Consumption - Cancer
The Cancer Trends Progress Report, continually updated since its first issue in 2001, summarizes our nation's advances against cancer in relation to Healthy People targets set forth by the …
Cancer risk decreases with more physical activity - NCI
Mar 26, 2025 · Learn more about the intramural research done in NCI’s Division of Cancer Epidemiology and Genetics. For more information about cancer, please visit the NCI website …
Cancer Imaging Program (CIP) - NCI
It also promotes imaging in clinical trials in order to gain greater understanding of the pathways of cancer biology for the benefit of cancer patients and people at cancer risk.
NIH study investigates trends in early-onset cancers - NCI
May 8, 2025 · Changes in cancer screening guidelines, advances in imaging technologies, and increased surveillance of high-risk individuals may also have led to earlier cancer diagnoses, …
Adjuvant Keytruda Improves Kidney Cancer Survival - NCI
May 21, 2024 · Pembrolizumab (Keytruda) treatment after surgery helped people with clear-cell renal cell carcinoma live longer in a large trial—a first for this cancer.